GENELUX CORPORATION Debt Securities, Available-for-sale, Unrealized Loss
GENELUX CORPORATION (GNLX) reported Debt Securities, Available-for-sale, Unrealized Loss of $5.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss · last filed 2026-08-13
- GENELUX CORPORATION debt securities, available-for-sale, unrealized loss for the quarter ending 2026-06-30 was -$3.00K.
- GENELUX CORPORATION debt securities, available-for-sale, unrealized loss for the quarter ending 2026-03-31 was $8.00K.
- GENELUX CORPORATION debt securities, available-for-sale, unrealized loss for the quarter ending 2024-06-30 was $6.00K.
- GENELUX CORPORATION debt securities, available-for-sale, unrealized loss for the quarter ending 2024-03-31 was $7.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss 3 month | Debt Securities, Available-for-sale, Unrealized Loss 6 month |
|---|---|---|
| 2026-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $5.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $8.00K 10-Q · filed 2026-05-07 | |
| 2025-06-30 | $5.00K 10-Q · filed 2025-08-07 | |
| 2024-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $13.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $7.00K 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |